Enhancing mRNA vaccine production: Optimization of in vitro transcription for improved yield and purity
Year: 2026
Type: article
Source: Biotechnology Progress
DOI: 10.1002/btpr.70109
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: MSD K.K.
OpenAlex ID: W7126182144